Javascript must be enabled to continue!
Interaction between SNPs in the NRF2 gene and elite endurance performance
View through CrossRef
Nuclear respiratory factor 2 (NRF2), a member of the Cap-N-Collar family of transcription factors, plays an important role in the mitochondrial biogenesis, and variants of NRF2 gene have been associated with endurance performance. The aims of the present study were 1) to compare NRF2 A/C (rs12594956) and NRF2 C/T (rs8031031) genotype and allele frequencies between athletes of sports with different demands (endurance vs. sprinters) as well as between competitive levels (elite level vs. national level) and 2) to analyze the interaction of these two polymorphisms and its influence on the level of endurance performance. One hundred and fifty-five track and field athletes (74 endurance athletes and 81 sprinters) and 240 nonathletic healthy individuals participated in this study. Endurance athletes presented a higher frequency of the AA (rs12594956) and CT (rs8031031) genotypes than sprinters and the control group, as well as higher A and T alleles, respectively. These differences did not appear between the sprinters and control subjects. The odds ratio for harboring the “optimal genotype” ( NRF2 AA+ NRF2 CT) was 4.53 (95% confidence interval 1.23–16.6) in the whole cohort of endurance athletes and 6.55 (95% confidence interval 1.12–38.25) in elite-level endurance athletes, compared with control subjects and both levels of sprinters. In conclusion, our data indicate that the NRF2 A/C and NRF2 C/T single nucleotide polymorphisms (SNPs) are associated, separately and in combination, with elite endurance athletes, which supports the notion that these specific gene variants might belong to a growing group of SNPs that are associated with endurance performance.
American Physiological Society
Title: Interaction between SNPs in the NRF2 gene and elite endurance performance
Description:
Nuclear respiratory factor 2 (NRF2), a member of the Cap-N-Collar family of transcription factors, plays an important role in the mitochondrial biogenesis, and variants of NRF2 gene have been associated with endurance performance.
The aims of the present study were 1) to compare NRF2 A/C (rs12594956) and NRF2 C/T (rs8031031) genotype and allele frequencies between athletes of sports with different demands (endurance vs.
sprinters) as well as between competitive levels (elite level vs.
national level) and 2) to analyze the interaction of these two polymorphisms and its influence on the level of endurance performance.
One hundred and fifty-five track and field athletes (74 endurance athletes and 81 sprinters) and 240 nonathletic healthy individuals participated in this study.
Endurance athletes presented a higher frequency of the AA (rs12594956) and CT (rs8031031) genotypes than sprinters and the control group, as well as higher A and T alleles, respectively.
These differences did not appear between the sprinters and control subjects.
The odds ratio for harboring the “optimal genotype” ( NRF2 AA+ NRF2 CT) was 4.
53 (95% confidence interval 1.
23–16.
6) in the whole cohort of endurance athletes and 6.
55 (95% confidence interval 1.
12–38.
25) in elite-level endurance athletes, compared with control subjects and both levels of sprinters.
In conclusion, our data indicate that the NRF2 A/C and NRF2 C/T single nucleotide polymorphisms (SNPs) are associated, separately and in combination, with elite endurance athletes, which supports the notion that these specific gene variants might belong to a growing group of SNPs that are associated with endurance performance.
Related Results
A Stress-Responsive Transcriptional Factor NRF2 Activates Hematopoietic Stem Cells
A Stress-Responsive Transcriptional Factor NRF2 Activates Hematopoietic Stem Cells
Abstract
KEAP1-NRF2 system is a major regulator of cellular redox balance and xenobiotic metabolism. NRF2 is an inducible transcription factor, and KEAP1 is its nega...
Functional Movement Screen® evaluation: comparison between elite and non-elite young swimmers
Functional Movement Screen® evaluation: comparison between elite and non-elite young swimmers
Functional Movement Screen® (FMS®) permite evaluar la funcionalidad del movimiento del atleta. La funcionalidad del movimiento en nadadores jóvenes de élite y no élite puede predec...
Abstract 391: Role of NRF2 in HIF-2α-mediated cancer stem cell phenotype
Abstract 391: Role of NRF2 in HIF-2α-mediated cancer stem cell phenotype
Abstract
The acquisition of cancer stem cell (CSC) properties is influenced by the microenvironment, with tumor hypoxia playing a pivotal role. Elevated levels of nu...
Nrf2 and Keap1 Gene Polymorphisms and Lower Extremity Atherosclerosis in the Elderly
Nrf2 and Keap1 Gene Polymorphisms and Lower Extremity Atherosclerosis in the Elderly
Objective: To investigate the association between Nuclear factor-erythroid 2-related factor 2 (Nrf2) and Kelch-like ECH-associated protein 1 (Keap1) gene polymorphisms and lower ex...
Trilobatin targets Nrf2 to ameliorate lipopolysaccharide-induced depressive-like behavior: Involvment of microbiota-gut-brain axis
Trilobatin targets Nrf2 to ameliorate lipopolysaccharide-induced depressive-like behavior: Involvment of microbiota-gut-brain axis
Abstract Background and Purpose: Activation of Nrf2 holds great promise
for treating major depressive disorder (MDD). Trilobatin (TLB) is a
naturally occurring food additive confer...
Abstract 436: NRF2 activity impairs the efficacy of sotorasib in human KRAS-mutant lung adenocarcinoma
Abstract 436: NRF2 activity impairs the efficacy of sotorasib in human KRAS-mutant lung adenocarcinoma
Abstract
Lung cancer continues to be the leading cause of cancer-related mortality in the United States, with lung adenocarcinoma (LUAD) representing the most common...
N6-methyladenosine-mediated Nrf2 Regulates the Defense Mechanism Against PM2.5-induced Pulmonary Fibrosis
N6-methyladenosine-mediated Nrf2 Regulates the Defense Mechanism Against PM2.5-induced Pulmonary Fibrosis
Abstract
Background: It has been reported that particulate matter with an aerodynamic diameter of < 2.5 µm (PM2.5) could induce epithelial–mesenchymal transition (EMT)- ...
A Mechanism Study on the Antioxidant Pathway of Keap1-Nrf2- ARE Inhibiting Ferroptosis in Dopaminergic Neurons
A Mechanism Study on the Antioxidant Pathway of Keap1-Nrf2- ARE Inhibiting Ferroptosis in Dopaminergic Neurons
Background:
The pathology of Parkinson's disease (PD) indicates that iron deposition
exists in dopaminergic neurons, which may be related to the death of cellular lipid iron peroxi...

